|
Markt geschlossen -
Nasdaq
22:00:00 25.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 0.6395 USD | -2.49% |
|
-2.01% | -59.53% |
| 27.08. | Outlook Therapeutics ernennt Kevin Lundquist zum CFO | MT |
| 27.08. | Outlook Therapeutics, Inc. kündigt Änderungen im Management an, wirksam zum 1. September 2026 | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.49% | -2.01% | +2.60% | -62.60% | -59.53% | -34.08% | -85.47% | -98.61% | -99.91% | 156 Mio. | |
| -0.14% | +4.33% | -3.16% | +6.47% | +5.84% | +9.00% | +31.64% | -23.35% | +212.06% | 47.97 Mrd. | |
| -1.69% | +1.48% | +3.39% | +41.45% | +19.95% | +50.57% | +34.53% | +3.35% | +242.33% | 44.5 Mrd. | |
| +2.56% | +7.34% | -4.86% | +12.57% | +157.34% | +366.69% | +608.26% | +567.44% | - | 43.93 Mrd. | |
| +0.24% | +2.85% | -3.98% | +28.93% | +18.77% | +10.67% | +94.47% | -4.92% | +1’123.22% | 41.03 Mrd. | |
| -0.62% | -1.11% | -8.27% | +6.93% | +2.91% | +4.65% | +48.91% | -21.39% | +130.13% | 29.85 Mrd. | |
| -0.28% | +1.07% | -0.03% | +17.42% | +10.19% | +24.58% | +155.58% | +212.23% | +2’031.86% | 17.27 Mrd. | |
| +3.37% | +9.21% | +24.14% | +51.43% | +43.96% | +8.32% | - | - | - | 15.34 Mrd. | |
| -0.46% | +1.20% | +6.23% | +12.18% | +23.97% | +26.90% | +42.21% | -35.50% | +92.37% | 15.3 Mrd. | |
| -2.21% | -4.70% | -9.85% | -13.48% | - | - | - | - | - | 14.82 Mrd. | |
| -0.54% | +5.32% | -0.77% | +35.73% | +46.80% | +97.12% | +50.61% | -36.10% | +254.96% | 13.98 Mrd. | |
| -0.90% | +5.01% | +2.01% | +1.45% | -5.43% | +5.21% | -30.15% | -39.11% | +126.78% | 13.3 Mrd. | |
| +8.05% | +9.15% | +21.51% | +264.21% | +245.73% | +173.85% | +120.66% | +34.40% | +1’825.56% | 12.48 Mrd. | |
| +0.06% | +0.33% | +0.32% | +2.27% | +23.47% | +40.04% | +7.54% | -46.10% | +168.30% | 11.39 Mrd. | |
| -3.38% | +0.46% | -1.54% | +65.27% | +53.01% | +29.58% | +49.28% | -54.81% | - | 10.96 Mrd. | |
| -3.33% | -4.93% | -10.83% | +3.54% | +43.88% | +99.02% | +630.27% | +79.12% | - | 9.31 Mrd. | |
| +3.29% | -0.80% | -6.36% | +16.39% | +62.42% | +110.41% | +711.09% | +654.17% | +681.60% | 9.18 Mrd. | |
| -0.85% | +1.96% | +1.89% | +12.10% | -6.67% | -4.39% | -0.07% | -26.88% | +43.72% | 9.14 Mrd. | |
| +0.55% | -10.00% | -18.43% | -3.08% | -31.98% | +16.50% | +437.40% | +166.78% | +927.60% | 8.14 Mrd. | |
| -0.36% | -6.08% | -25.60% | -14.34% | -4.74% | +435.43% | +1’164.78% | -6.31% | - | 7.84 Mrd. | |
| Durchschnitt | +0.04% | +0.94% | -1.58% | +24.24% | +34.21% | +77.37% | +226.19% | +73.58% | +554.33% | 18.79 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.18% | +2.29% | -1.40% | +26.29% | +42.28% | +83.50% | +190.77% | +93.45% | +553.85% |
- Börse
- Aktien
- A4046T Aktie
- Sektor Outlook Therapeutics, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
